Agostina Nardone

2.1k total citations
25 papers, 440 citations indexed

About

Agostina Nardone is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Agostina Nardone has authored 25 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Agostina Nardone's work include Advanced Breast Cancer Therapies (8 papers), Estrogen and related hormone effects (6 papers) and HER2/EGFR in Cancer Research (6 papers). Agostina Nardone is often cited by papers focused on Advanced Breast Cancer Therapies (8 papers), Estrogen and related hormone effects (6 papers) and HER2/EGFR in Cancer Research (6 papers). Agostina Nardone collaborates with scholars based in United States, Italy and Canada. Agostina Nardone's co-authors include Rachel Schiff, C. Kent Osborne, Carmine De Angelis, Meghana V. Trivedi, Xiaoyong Fu, Bianca Maria Veneziani, Susan G. Hilsenbeck, Martin J. Shea, Sara Corvigno and Nicholas Mitsiades and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Agostina Nardone

24 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agostina Nardone United States 9 264 194 114 89 87 25 440
Fernando J. López-Díaz United States 8 357 1.4× 154 0.8× 115 1.0× 53 0.6× 103 1.2× 15 499
John P. Gustin United States 11 512 1.9× 206 1.1× 109 1.0× 67 0.8× 150 1.7× 12 641
Constance M. Cultraro United States 14 381 1.4× 166 0.9× 109 1.0× 27 0.3× 65 0.7× 30 510
Karijn Floor Netherlands 10 400 1.5× 244 1.3× 179 1.6× 43 0.5× 100 1.1× 12 588
Eniko Papp United States 5 229 0.9× 144 0.7× 60 0.5× 116 1.3× 255 2.9× 11 479
Alexey V. Bazarov United States 10 333 1.3× 266 1.4× 91 0.8× 27 0.3× 117 1.3× 12 525
Elizabeth Blackwood United States 10 351 1.3× 194 1.0× 36 0.3× 39 0.4× 55 0.6× 26 465
B. Corkery Ireland 5 204 0.8× 284 1.5× 108 0.9× 25 0.3× 141 1.6× 9 450
Alexandra Corella United States 8 251 1.0× 161 0.8× 183 1.6× 29 0.3× 101 1.2× 11 438
Subrata Manna United States 8 179 0.7× 124 0.6× 31 0.3× 84 0.9× 106 1.2× 12 358

Countries citing papers authored by Agostina Nardone

Since Specialization
Citations

This map shows the geographic impact of Agostina Nardone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agostina Nardone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agostina Nardone more than expected).

Fields of papers citing papers by Agostina Nardone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agostina Nardone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agostina Nardone. The network helps show where Agostina Nardone may publish in the future.

Co-authorship network of co-authors of Agostina Nardone

This figure shows the co-authorship network connecting the top 25 collaborators of Agostina Nardone. A scholar is included among the top collaborators of Agostina Nardone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agostina Nardone. Agostina Nardone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nardone, Agostina, Damien Friel, Francisco Hermida‐Prado, et al.. (2025). Imlunestrant a next-generation oral SERD overcomes ESR1 mutant resistance in estrogen receptor–positive breast cancer. JCI Insight. 10(12). 1 indexed citations
2.
Nardone, Agostina, Nicola Casiraghi, Francesca Galardi, et al.. (2025). Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer. npj Breast Cancer. 11(1). 25–25. 2 indexed citations
3.
Migliaccio, Ilenia, Martina Bonechi, Dario Romagnoli, et al.. (2025). Single-cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell lines. npj Breast Cancer. 11(1). 82–82.
4.
Grinshpun, Albert, Wen Ma, Giorgio Gaglia, et al.. (2024). Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer. npj Breast Cancer. 10(1). 42–42. 3 indexed citations
5.
Migliaccio, Ilenia, Dario Romagnoli, Francesca Galardi, et al.. (2024). Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial. JCO Precision Oncology. 8(8). e2300285–e2300285. 4 indexed citations
6.
Stein, Shayna, Agostina Nardone, Weihan Liu, et al.. (2023). Mathematical Modeling Identifies Optimum Palbociclib-fulvestrant Dose Administration Schedules for the Treatment of Patients with Estrogen Receptor–positive Breast Cancer. Cancer Research Communications. 3(11). 2331–2344. 5 indexed citations
7.
Romagnoli, Dario, Agostina Nardone, Francesca Galardi, et al.. (2023). MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples. Briefings in Bioinformatics. 24(2). 1 indexed citations
8.
Guarducci, Cristina, Simona Cristea, Avery Feit, et al.. (2023). Abstract GS3-07: GS3-07 Clonal evolution and mechanisms of acquired resistance to CDK4/6 inhibitors in ER-wild type and ER-mutant breast cancer. Cancer Research. 83(5_Supplement). GS3–7. 3 indexed citations
9.
10.
Guarducci, Cristina, Agostina Nardone, Ariel Feiglin, et al.. (2019). Abstract PD7-12: Inhibition of CDK7 overcomes resistance to CDK4/6 inhibitors in hormone receptor positive breast cancer cells. Cancer Research. 79(4_Supplement). PD7–12. 15 indexed citations
11.
Montanari, Micaela, Vittoria Carbone, Luigi Coppola, et al.. (2018). Epigenetic Silencing of THY1 Tracks the Acquisition of the Notch1–EGFR Signaling in a Xenograft Model of CD44+/CD24low/CD90+ Myoepithelial Cells. Molecular Cancer Research. 17(2). 628–641. 7 indexed citations
12.
Nardone, Agostina, Hazel M. Weir, Oona Delpuech, et al.. (2018). The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance. British Journal of Cancer. 120(3). 331–339. 43 indexed citations
13.
Angelis, Claudia De, Agostina Nardone, Xiaoyong Fu, et al.. (2017). Abstract S4-01: A novel BRD4 inhibitor enhances endocrine therapy efficacy and circumvents endocrine-resistance in estrogen receptor-positive breast cancer models. Cancer Research. 77(4_Supplement). S4–1. 2 indexed citations
14.
Nardone, Agostina, Carmine De Angelis, Meghana V. Trivedi, C. Kent Osborne, & Rachel Schiff. (2015). The changing role of ER in endocrine resistance. The Breast. 24. S60–S66. 91 indexed citations
15.
Fu, Xiaoyong, Rinath Jeselsohn, Dolores López‐Terrada, et al.. (2015). Abstract PD6-2: FoxA1 gene amplification in ER+ breast cancer mediates endocrine resistance by increasing IL-8. Cancer Research. 75(9_Supplement). PD6–2. 1 indexed citations
16.
Feng, Qin, Zheng Zhang, Martin J. Shea, et al.. (2014). An epigenomic approach to therapy for tamoxifen-resistant breast cancer. Cell Research. 24(7). 809–819. 151 indexed citations
17.
Leccia, F., Agostina Nardone, Sara Corvigno, et al.. (2012). Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes. Cytometry Part A. 81A(11). 960–972. 35 indexed citations
18.
Nardone, Agostina, et al.. (2010). Long-term cultures of stem/progenitor cells from lobular and ductal breast carcinomas under non-adherent conditions. Cytotechnology. 63(1). 67–80. 10 indexed citations
19.
Cavaliere, Carla, Sara Corvigno, Mario Galgani, et al.. (2010). Combined inhibitory effect of formestane and herceptin on a subpopulation of CD44+/CD24low breast cancer cells. Cancer Science. 101(7). 1661–1669. 9 indexed citations
20.
Nardone, Agostina, Carla Cavaliere, Sara Corvigno, et al.. (2009). A banking strategy toward customized therapy in breast cancer. Cell and Tissue Banking. 10(4). 301–308. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fernando J. López-Díaz Breakdown of academic impact, for papers by John P. Gustin Breakdown of academic impact, for papers by Constance M. Cultraro Breakdown of academic impact, for papers by Karijn Floor Breakdown of academic impact, for papers by Eniko Papp Breakdown of academic impact, for papers by Alexey V. Bazarov Breakdown of academic impact, for papers by Elizabeth Blackwood Breakdown of academic impact, for papers by B. Corkery Breakdown of academic impact, for papers by Alexandra Corella Breakdown of academic impact, for papers by Subrata Manna
Rankless by CCL
2026